Policy changes Backwork has recorded, newest first. The most recent change on record is from October 2, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,180 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 2, 2026 | EviCore by Evernorth | Omalizumab (Xolair) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Olipudase Alfa-rpcp (Xenpozyme) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Octreotide Products (Sandostatin, Sandostatin LAR) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Octreotide Products (Sandostatin, Sandostatin LAR) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Octreotide Products (Sandostatin, Sandostatin LAR) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Octreotide Acetate Long-acting Products (Sandostatin LAR Depot, generic) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Octreotide acetate injection (Sandostatin LAR Depot, Sandostatin) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Octreotide acetate injection (Sandostatin LAR Depot, Sandostatin) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Octreotide acetate injection (Sandostatin LAR Depot, Sandostatin) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocriplasmin (Jetrea) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocrevus (ocrelizumab) Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocrevus (ocrelizumab) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Obizur (Antihemophilic Factor [Recombinant], Porcine Sequence) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nusinersen (Spinraza) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nusinersen (Spinraza) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nusinersen (Spinraza) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nusinersen (Spinraza) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nusinersen (Spinraza) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nusinersen (Spinraza) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nulojix (belatacept) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nulibry (fosdenopterin) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nulibry (fosdenopterin) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nulibry (fosdenopterin) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nucala (mepolizumab) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nucala (mepolizumab) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nucala (mepolizumab) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nplate (romiplostim) Non-oncology | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | NovoSeven RT (coagulation factor VIIa [recombinant]) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nexviazyme (avalglucosidase alfa-ngpt) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Nexviazyme (avalglucosidase alfa-ngpt) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | New Specialty Drugs | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | New Specialty Drugs | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | New Medical Drug Management Policy | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | New Medical Drug Management Policy | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | New Medical Drug / Indication | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Natalizumab (Tysarbi) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Natalizumab (Tysabri) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Natalizumab (Tysabri) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Natalizumab (Tysabri) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Natalizumab (Tysabri) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Natalizumab (Tysabri) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Natalizumab (Tysabri) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Natalizumab (Tysabri) | Metadata changed |
| Oct 2, 2026 | EviCore by Evernorth | Naltrexone (Vivitrol) | Metadata changed |